Abstract
Introduction
In urine cytology, BK virus (BKV)-infected cells are detected as decoy cells, most of which are thought to originate from the renal tubules [1] [2] [3] 5] . The detection of decoy cells is generally used as a supporting technique for BKV nephropathy in kidney-transplantation patients [4] [5] [6] . 50 BKV infection is common in adults with a reported prevalence of more than 80%; the infection usually occurs in early childhood. Reactivations may occur in conditions associated with impaired immunity [7] [8] [9] . BKV infection usually occurs in the urothelial cells of the bladder Bone marrow transplant patients with BKV infection often suffer from hemorrhagic cystitis, and kidney transplantation is associated with BKV nephropathy; the treatments for each of these conditions differ [11, 12] . Identifying the site of BKV infection is important for determining the appropriate therapeutic strategy.
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Detection of decoy cells by urine cytology is generally performed for diagnosis of BKV infection, in addition to direct detection of BKV by PCR [13, 14] . Although PCR is highly sensitive and specific, it cannot identify the site of BKV infection [15] . It is difficult to discriminate between renal tubular epithelial cells and urothelial cells by cytological morphology and a specific antibody to distinguish these cells from each other was not available until recently.
In this study, we attempted to identify the origin of BKV-infected cells in clinical urine samples by simultaneous immunostaining. We used anti-S100P (an urothelial marker) and anti-SV40 antibodies [16] [17] [18] . Anti-SV40 antibody is commonly used to identify BKV infection because it provides the advantage of cross-reactivity between SV40 and BKV 70 [19] [20] [21] .
Material and Methods

Materials
The institutional research board of Okayama Medical Center approved this study. Among [10, 22] . We excluded 85 SV40-negative cells exhibiting a decoy-cell appearance and SV40-positive cells without a decoy-cell appearance. To confirm the specificity of S100P for urothelial epithelium, we examined autopsy specimens of normal tissue sections from the bladder and kidney cases with no kidney and urinary tract disease. We examined the tissue sections of BKV-infected kidney to confirm that the renal tubular epithelia were positive for SV40 and negative for S100P.
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Confirmation of S100P immunostaining
Non-fixed autopsy specimens of bladder mucous membrane and renal parenchyma were Red Chromogen Kit 2 (Biocare Medical, Concord, CA) was used for counterstaining.
Formalin-fixed paraffin-embedded sections of urinary bladders and kidneys sampled from autopsy cases were immunostained with anti-S100P antibody and compared to the cytology samples.
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Simultaneous immunostaining with the primary antibody cocktail
Urine samples were obtained by SP-LBC. Simultaneous immunostaining was conducted in each of the 66 cases as described in Table 2 . Heat-induced antigen retrieval using a pressure cooker was performed with Target Retrieval Solution (pH 9.0, Dako, Carpinteria, CA) for 10 min. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide for 10 min. The 110 anti-S100P (Atlas antibodies, Sweden) and anti-SV 40 (Calbiochem, CA) primary antibodies were mixed prior to the reaction (Table 1) , which was completed in one step for 40 min at room temperature. Secondary antibodies were reacted with MACH2 double stain 2 (Biocare Medical, Concord, CA) for 30 min. Enzyme reactions were visualized by incubation with 3-3′-diaminobezidine-4HCl and the Vulcan Fast Red Chromogen Kit 2 [24] .
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Results
Confirmation of S100P immunostaining
Positive S100P immunostaining was detected in the cytoplasm of bladder urothelial cells ( Fig. 1-a) , but not in the renal tubule epithelial cells ( Fig. 1-b) . Similarly, suspended urothelial 120 cells were S100P-positive and suspended renal tubular epithelial cells were S100P-negative ( Fig. 1-c, d ). Almost all suspended urothelial cells (96%) were positive for S100P, whereas suspended renal tubular epithelial cells were completely negative. Small numbers of S100P-positive cells in the suspended renal tubular epithelial cells were also positive for LCA (leukocyte common antigen), indicating that they were leukocytes.
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Simultaneous immunostaining with the primary antibody cocktail
The cytoplasm of the renal pelvic urothelial cells was positive for S100P (red) in BKV-infected kidney samples (Fig. 2-a, b) . The nuclei of BKV-infected renal tubular epithelial cells were positive for SV40 (brown), but the cytoplasm was negative for S100P ( Fig. 2-a, c) .
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The BKV-infected (SV40-positive) cells in urine cytology samples were categorized as SV40(+)/S100P(+) (Fig. 2e ) and SV40(+)/S100p(-) (Fig. 2f) . SV40(+)/S100p(-) cells were found in 55/66 cases (83.4%), and 9/66 (13.6%) cases had both SV40(+)/S100P(+) and SV40(+)/S100p(-) cells. The remaining two cases (3.0%) had only SV40(+)/S100P(+) cells.
135
Discussion
In this study, urothelial cells and renal tubular epithelial cells in clinical urine samples were differentiated by S100P-immunostaining. S100P is a member of the S100 protein family, and plays important roles in cell cycle control and differentiation [16] [17] [18] . S100P was initially identified in the placenta, and subsequently identified in the mucosal epithelia of the 140 gastrointestinal tract, epithelial cells of the prostate gland, white blood cells, and urothelial cells of the bladder and renal pelvis [16] [17] [18] . In addition, S100P has recently been recognized as a urothelial marker for the renal pelvic urothelium and bladder urothelium [16] [17] [18] . In this study, 96% of suspended urothelial cells were positive for S100P, and the suspended renal tubular epithelial cells were completely negative. In the urinary tract, squamous cells and renal 145 tubular epithelial cells are negative for S100P, but can be distinguished from each other by their morphology. We conclude that S100P is a useful marker for differentiation of urothelial cells from renal tubular epithelial cells in clinical urine samples.
In this study, BKV-infected cells in clinical urine samples were classified as SV40(+)/S100P(+) or SV40(+)/S100P(-). In BKV-infected kidney tissue, the infected renal 150 tubular epithelial cells were SV40(+)/S100P(-) (Fig. 2c) . Therefore, we conclude that SV40(+)/S100P(+) cells originate from the urothelia and SV40(+)/S100P ( This study shows that simultaneous immunostaining for S100P and SV40 is a quick, useful method for determining the origin of BKV-infected cells in clinical urine samples. As a screening tool for urinary tract BKV infections, we believe this method can add value to 170 cytological examinations and may be useful for analyzing renal biopsy specimens in patients with suspected BKV nephropathy, in whom BKV is detected by PCR. BKV-infected bone marrow transplant patients tend to suffer from hemorrhagic cystitis, while kidney-transplant tends to be associated with BKV nephropathy [11, 12] . The treatments for these conditions differ, so it is important to identify the infected site before choosing a therapeutic strategy. A 175 few cases of the BKV-related urothelial carcinoma have been reported in recent years [26]; we believe our method may provide useful clues to the origin of BKV-infected cells in these cases.
The merits of this method include low cost and convenience; the method requires only a few staining steps and can be completed in as little as 4 h from sample preparation to staining and identification. In addition, the method requires no special equipment or techniques, and is 180 practical for use in facilities with limited experience.
Conclusion
Simultaneous immunostaining with anti-S100P and anti-SV40 antibodies can be used to 
